Human health cannot be separated from ocean health. Our oceans produce half of the earth’s oxygen, stores a quarter of emitted CO2, and over a billion people depend on it as their primary source of protein.
We believe that our under-explored diversity-rich oceans also hold the key to finding new medicines for a host of diseases through bio-pharmaceutical research, drug discovery and biomimetic-inspired medical devices. Today, however, our oceans are under siege by climate change, pollution and overfishing. All three are depleting marine populations, leading to mass extinctions of known and yet-to-be-discovered species.
Our mission is to mitigate these threats by assisting companies in commercializing innovative technologies designed to aid in the conservation of marine environments and the exploration and collection of marine life. Our goal is to preserve the great promise our oceans offer as a treasure trove of pharmaceuticals and natural products to combat illness and improve our quality of life.
While reefs occupy less than 0.1% of the world’s ocean area, they provide a home for at least 25% of all known marine species. Over the last three decades, the world has lost half its coral reefs due to temperature rise and acidification. This loss is changing the distribution of fish stocks and driving many species to extinction.
Overfishing depletes species and can destroy fragile ecosystems. It’s estimated that more than 30% of global fisheries are being exploited at unsustainable levels and another 60% are at max capacity.
Pollution, such as plastics and raw sewage, also kills species through poisoning and oxygen depletion. The loss of marine biodiversity doesn’t just threaten sources of human food, but also can deprive us of potential new medical treatments and cures for a wide variety of diseases.
The ocean covers three quarters of the Earth’s surface and hosts more than 80% of diverse plant and animal species in the world, yet less than 10% of marine species have been discovered & catalogued to date. It is widely believed that our under-explored diversity-rich oceans hold the key to finding medicines for a host of diseases. Many new marine-based drugs have already been discovered that treat some types of cancer, antibiotic resistant staph infections, pain, asthma, and inflammation.
Our goal is to work with companies focused on technologies designed to reduce the time and cost to discover and bring new species of marine animals and plants from the ocean bottom to the lab.
Nolstar proudly supports United Nations 2030 Sustainable Development Goals with particular emphasis on SGD03 and SGD14
We offer a suite of services designed to meet your company’s particular needs. This can include pre-launch activities ranging from initial product assessment, market research, and customer discovery, to product launch, business development, and exit strategy.
At Nolstar, we excel when operating in a small company environment where resources are limited, a lean infrastructure exits, and the cycle time for making decisions is relatively compressed. As such, we apply a collaborative phased-gate methodology to guide strategic decision making. By utilizing this approach, we strive to save your company both time and money.
The scope and deliverables of each project will be determined in advance. All will have a clear start and finish date with milestones to judge performance and keep things on schedule. By utilizing this approach, Nolstar can help guide and accelerate the transition of your technology from an idea into a commercial product regardless of its current stage of development.
Whether you are in the idea phase or have a working prototype, we are here to help. Our services include commercial assessment, market research, risk analysis, customer discovery, market requirements, market validation, product positioning, and product launch.
We can also help you to perfect your elevator pitch and pitch-deck for fundraising and/or acceptance into an accelerator program.
If your company is about to launch a product or is already in the marketplace, we can help you scale and grow your business. We have extensive experience in developing market expansion strategies and in sourcing, vetting and managing distribution partners.
We also offer assistance with post-market surveillance, sourcing strategic partners, and identifying strategic targets for acquisition.
Should you decide to sell your business or license your technology, Nolstar can help. We offer M&A intermediary services through our alliance with Genuine Business Advisors to find an optimal buyer.
Our services include conducting valuations, managing due diligence, writing confidential information memorandums (CIM), designing presentations, and contacting prospective buyers and strategic partners for your company’s business or IP. Once an offer is accepted, we manage the transaction through closing.
If you are interested in learning more about our services or would just like to connect to discuss an idea for a new product, please complete the fields below.
Copyright © 2024 Nolstar LLC, Boston, Massachusetts 02109 USA. All Rights Reserved
Social network
